| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.25 | 4e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-10 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |